Eulerpool Terminal
The edge that pays for itself.
Current Mayne Pharma Group forecasts and price targets in August 2026
Ø Analyst Price Targets
6.22 AUD
+94.44 %
Median
6.22 AUD
+94.44 %
Max
6.41 AUD
Min
6.16 AUD
Last Price
3.20 AUD
Buy
4
Hold
1
Sell
0
The average target price for Mayne Pharma Group is 6.22 AUD. (+94.44 % above the current price)
The median price target of Mayne Pharma Group is 6.22 AUD.
Stock analysts from many renowned investment banks are closely examining the Mayne Pharma Group stock. They conclude their professional Mayne Pharma Group stock analyses with a clear recommendation for the Mayne Pharma Group stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-03-01 | 4 | 1 | 0 | — |
| 2026-02-01 | 4 | 1 | 0 | 6.22 AUD |
| 2026-02-01 | 4 | 1 | 0 | 6.22 AUD |
| 2026-01-01 | 4 | 1 | 0 | 6.22 AUD |
| 2025-12-01 | 4 | 1 | 0 | 6.22 AUD |
| 2025-12-01 | 4 | 1 | 0 | 6.22 AUD |
Mayne Pharma Group Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Mayne Pharma Group in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 399.00 M AUD | -37.00 M AUD | -0.47 AUD |
| 2027e | 400.00 M AUD | -28.00 M AUD | -0.35 AUD |
| 2028e | 410.00 M AUD | -18.00 M AUD | -0.23 AUD |